Mirum Pharmaceuticals, Inc.

Q2 2026 13F Holders

Symbol
MIRM
CUSIP
604749101
Type
Equity
Class
COM
Num filings
337
Total reported value, excl. options
$8.41 B
Manager Report Date Value ($000) Shares Option Type